Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1591 AL 1605

123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes

Hellwig S, Kreft A, Amtage F, Tüscher O, Winz OH, Hellwig B, Weiller C, Weber WA, Vach W, Meyer PT.

J Nucl Med. 2013 Dec;54(12):2081-6. doi: 10.2967/jnumed.113.122010. Epub 2013 Oct 10.

8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications

Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V.

Drug Des Devel Ther. 2013 Oct 4;7:1157-78. doi: 10.2147/DDDT.S49763. eCollection 2013.

The effects of adapted tango on spatial cognition and disease severity in Parkinson's disease

McKee KE, Hackney ME.

J Mot Behav. 2013;45(6):519-29. doi: 10.1080/00222895.2013.834288. Epub 2013 Oct 11.

Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life

Weerkamp NJ, Tissingh G, Poels PJ, Zuidema SU, Munneke M, Koopmans RT, Bloem BR.

J Am Geriatr Soc. 2013 Oct;61(10):1714-21. doi: 10.1111/jgs.12458. Epub 2013 Oct 1.

Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action

Borah A, Paul R, Choudhury S, Choudhury A, Bhuyan B, Das Talukdar A, Dutta Choudhury M, Mohanakumar KP.

CNS Neurosci Ther. 2013 Nov;19(11):847-53. doi: 10.1111/cns.12175. Epub 2013 Oct 14.

Physical activity and the brain: a review of this dynamic, bi-directional relationship

Loprinzi PD, Herod SM, Cardinal BJ, Noakes TD.

Brain Res. 2013 Nov 20;1539:95-104. doi: 10.1016/j.brainres.2013.10.004. Epub 2013 Oct 9.

[Freezing and gait disorders in Parkinson's disease]

Gonçalves G, Pereira J.

Rev Med Chil. 2013 Jun;141(6):758-64. doi: 10.4067/S0034-98872013000600010.

A comparative computational investigation on the proton and hydride transfer mechanisms of monoamine oxidase using model molecules

Atalay VE, Erdem SS.

Comput Biol Chem. 2013 Dec;47:181-91. doi: 10.1016/j.compbiolchem.2013.08.007. Epub 2013 Sep 20.

Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls

Herbert MK, Kuiperij H, Bloem BR, Verbeek MM.

J Neurol. 2013 Dec;260(12):3129-33. doi: 10.1007/s00415-013-7126-5.

Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease

Ylönen S, Ylikotila P, Siitonen A, Finnilä S, Autere J, Majamaa K.

J Neurol. 2013 Dec;260(12):3144-9. doi: 10.1007/s00415-013-7132-7.

Dopamine overdose hypothesis: evidence and clinical implications

Vaillancourt DE, Schonfeld D, Kwak Y, Bohnen NI, Seidler R.

Mov Disord. 2013 Dec;28(14):1920-9. doi: 10.1002/mds.25687. Epub 2013 Oct 9.

Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease

Pachana NA, Egan SJ, Laidlaw K, Dissanayaka N, Byrne GJ, Brockman S, Marsh R, Starkstein S.

Mov Disord. 2013 Dec;28(14):1930-4. doi: 10.1002/mds.25689. Epub 2013 Oct 9.

Dementia in Parkinson's disease: usefulness of the pill questionnaire

Martinez-Martin P.

Mov Disord. 2013 Nov;28(13):1832-7. doi: 10.1002/mds.25649. Epub 2013 Oct 7.

Protein misfolding and aggregation research: some thoughts on improving quality and utility

Murphy RM, Roberts CJ.

Biotechnol Prog. 2013 Sep-Oct;29(5):1109-15. doi: 10.1002/btpr.1812. Epub 2013 Oct 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias